Scientists could soon develop personalized cancer vaccines.

CAMBRIDGE, MA / ACCESS Newswire / April 6, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Company will ...

Investigators sought to determine the long-term effects of COVID-19 infection and vaccination in patients with solid malignancies.

Research into areas like cancer could become collateral damage of a broader anti-mRNA push, according to a new study.

The COVID pandemic ushered mRNA vaccines into the spotlight, and the technology has even greater potential. Here’s what to ...

The FDA is reviewing the first mRNA flu vaccine for adults 50 and older. Learn how this technology could lead to faster and ...

States target mRNA vaccines as weapons despite medical consensus, creating legal battles over established vaccine safety data ...

One example of this potential comes from studies on glioblastoma, an aggressive brain tumor with few effective treatments.

Penn Engineers have redesigned a key component of lipid nanoparticles (LNPs), the delivery vehicles behind mRNA vaccines, to ...

There's renewed debate on the future of mRNA vaccines, and Johns Hopkins researchers want to clear up some misconceptions around the shots. The mRNA vaccines gained attention during the height of ...

OpenAI CEO shared stories of some incredible ChatGPT and CODEX successes, but what do they mean for you (and your doing)?